Measurable Residual Disease, Conditioning Regimen Intensity and Age Predict Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Remission: A Registry Analysis of 2292 Patients by the Acute Leukemia Working Party Eu

American Journal of Hematology - United States
doi 10.1002/ajh.25211
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Myeloid Leukemia

Cancer Control
MedicineOncologyHematology
2011English

Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- A Report From the Acute Leukemia Working Party of the EBMT

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia Over 70 Years of Age: On Behalf of the Acute Leukemia Working Party of the EBMT

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Inferior Outcome of Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in First Complete Remission as Compared to De Novo Acute Myeloid Leukemia

Blood Cancer Journal
OncologyHematology
2020English

Allogeneic Stem Cell Transplantation Outcomes in Acute Myeloid Leukemia Patients With T(8;21)(q22;q22) in First Remission According to Conditioning Regimen

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Impact of Graft-Versus-Host Disease After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

The Role of Measurable Residual Disease (MRD) at Time of Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Lymphoblastic Leukemia Transplanted After Myeloablative Conditioning. A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Prognostic Value of Prior Consolidation in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation in Minimal Residual Disease-Negative First Complete Remission

American Journal of Hematology
Hematology
2018English

Post-Remission Strategies for the Prevention of Relapse Following Allogeneic Hematopoietic Cell Transplantation for High-Risk Acute Myeloid Leukemia: Expert Review From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy